Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
CEND-1 in Combination With Neoadjuvant FOLFIRINOX With or Without Panitumumab - Drug Trials For Money - Paid Clinical Trials

CEND-1 in Combination With Neoadjuvant FOLFIRINOX With or Without Panitumumab

CEND-1 in Combination With Neoadjuvant FOLFIRINOX With or Without Panitumumab
Conditions:   Colon Cancer;   Pancreas Cancer;   Digestive Cancer
Interventions:   Drug: CEND-1;   Drug: Panitumumab;   Drug: Folfirinox
Sponsors:   Anup Kasi;   Cend Therapeutics Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 25, 2021 / by / in
Comments